TORONTO, Feb. 06, 2023 (GLOBE NEWSWIRE) — Axiom Real-Time Metrics (“Axiom”), a leading provider of unified eClinical solutions and services focused on small to medium-sized life science organizations, will be exhibiting at the Exhibit SCOPE 2023, 7.-8. February in Orlando, FL.
The 14thth The annual SCOPE Summit brings together key industry leaders to connect and discuss solutions in all aspects of clinical trial innovation, planning, management and operations. The conference brings together pharma and biotech professionals to network and find solutions to current challenges related to clinical trials.
“Axiom’s Fusion eClinical Suite provides clients and research centers with a single point of access to all of their study data and clinical operational needs. The benefit of Fusion’s real-time reporting of data across multiple modules such as EDC, RTSM, ePRO and eConsent means instant insight into data trends in key areas to better manage your study,” said Brian Dempster, VP Global Clinical Management.
Global delivery of data-driven studies focused on S/M Lifescience needs
Founded in 2001, Axiom has long established itself as one of the leading global players and delivery experts in eClinical technology. The Axiom Fusion eClinical Suite enables small to medium life science companies to transform the way they manage clinical trials in the US and around the world. It also offers unlimited, real-time study reports and an awareness of what’s working and where critical issues need attention.
Axiom invites attendees to visit the team at booth 131 to discuss upcoming trial strategy, eClinical and service requirements, and how we can help you run your clinical trials easier, faster, and smarter.
To register for this event, please visit: SCOPE SUMMIT (cambridgeinnovationinstitute.com)
Learn more about Axiom’s Fusion eClinical Suite: https://www.axiommetrics.com/fusion-eclinical-suite/
About Axiom real-time metrics
Axiom celebrates 22 years of delivering hundreds of studies in dozens…
[ad_2]
Source story
